De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma

De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Lung Cancer - Volume 114, December 2017, Pages 108-110

Brian J. Carney, Deepa Rangachari, Paul A. VanderLaan, Kyle Gowen, Alexa B. Schrock, Siraj M. Ali, Daniel B. Costa,